BRIEF-Nordic Nanovector, Legochem Biosciences to jointly develop ADCs targeting leukaemias
Oct 10 Nordic Nanovector ASA :
* Says has entered into cooperation with Legochem Biosciences, South Korea-based biopharmaceutical company, to develop novel antibody-drug conjugates (ADCs) targeting leukaemias
* Says collaboration supports co's strategy to expand its pipeline of targeted therapies to include CD37-targeting antibody products conjugated to anti-cancer compounds that are not radionuclides Source text for Eikon: Further company coverage: (Gdynia Newsroom)
Aixtron, Fujian to explore what is left of deal after U.S. veto
FRANKFURT, Dec 3 German semiconductor equipment maker Aixtron will explore with its Chinese suitor what can be salvaged of the planned takeover after a U.S. presidential order ruled the deal posed a national security risk, the company said on Saturday.